Focus: Cello Therapeutics is a San Diego-based biotechnology company specializing in nanoparticle delivery platform technology. Scale and market position cannot be determined from available data.
Profile data last refreshed 1h ago · AI intelligence enriched 2mo ago
Growing — net +10 jobs in 30d
10 jobs added vs 0 removed. Steady team buildout.
Cello represents a high-risk, early-stage opportunity with limited visibility into pipeline maturity and hiring momentum.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Cello Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Cello Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo